![Mark Parry Billings](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Parry Billings
Director/Miembro de la Junta en Atopix Therapeutics Ltd. .
Perfil
Mark Parry Billings has been a Director at Atopix Therapeutics Ltd.
since 2016.
Cargos activos de Mark Parry Billings
Empresas | Cargo | Inicio |
---|---|---|
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Director/Miembro de la Junta | 17/11/2016 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Atopix Therapeutics Ltd.
![]() Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Parry Billings